[Therapy of acute lung failure--is there really something new?]

[New challenges for intensive care medicine due to climate change and global warming].

Der Anaesthesist·2020

[Update and Comment on the German S3 "Clinical Guideline for Treating Acute Respiratory Insufficiency with Invasive Ventilation and Extracorporeal Membrane Oxygenation: Evidence-Based Recommendations"].

Pneumologie (Stuttgart, Germany)·2020

[Health services research in intensive care medicine in Germany : Status quo and future challenges exemplified by acute pulmonary failure].

Der Anaesthesist·2019

[Indications and limitations of ECMO therapy : Considerations on evidence, treatment decisions and ethical challenges].

Medizinische Klinik, Intensivmedizin und Notfallmedizin·2019

[Impact of nursing staff shortage on intensive care medicine capacity in Germany].

Medizinische Klinik, Intensivmedizin und Notfallmedizin·2018

[Influence of social characteristics on the duration of treatment, severity of the disease and social support of patients in a surgical intensive care unit].

Der Anaesthesist·2018

[Management of chronic wounds in general practice].

Praxis·2026

[Rapid progression of neurological symptoms in an adult].

Praxis·2026

[On the wrong track: Misled by the patient history].

Praxis·2026

[An unusual cause for unilateral eye pain with double vision].

Praxis·2026

[Drug-induced liver injury (DILI)].

Praxis·2026

[What do Swiss doctors think about cardiovascular risk factors and guidelines?]

Praxis·2026

Polycation chain length determines the in vivo mRNA delivery efficiency of block copolymer micelles.

Biomaterials science·2026

Driving Drugs Deeper: Force-Driven Microneedle Systems for Active Therapy and Their Road Towards Clinical Implementation.

Small (Weinheim an der Bergstrasse, Germany)·2026

Mumio Potentiates Temozolomide by Inducing Apoptosis and Ferroptosis in Glioblastoma Cells.

Current pharmaceutical design·2026

Current Targeted Nanoparticle Therapy for Alzheimer's Disease: Current Advances and Future Prospects.

Current neurovascular research·2026

Clinical Presentation, Diagnosis, Treatment, and Outcome of Heart Disease in Becker Muscular Dystrophy.

Anatolian journal of cardiology·2026

Clinical Pharmacology of Eplontersen, the First Approved GalNAc-Conjugated Antisense Oligonucleotide.

Journal of clinical pharmacology·2026

Related Experiment Videos

[Therapy of acute lung failure--is there really something new?]

Related Concept Videos

[New challenges for intensive care medicine due to climate change and global warming].

[Update and Comment on the German S3 "Clinical Guideline for Treating Acute Respiratory Insufficiency with Invasive Ventilation and Extracorporeal Membrane Oxygenation: Evidence-Based Recommendations"].

[Health services research in intensive care medicine in Germany : Status quo and future challenges exemplified by acute pulmonary failure].

[Indications and limitations of ECMO therapy : Considerations on evidence, treatment decisions and ethical challenges].

[Impact of nursing staff shortage on intensive care medicine capacity in Germany].

[Influence of social characteristics on the duration of treatment, severity of the disease and social support of patients in a surgical intensive care unit].

[Management of chronic wounds in general practice].

[Rapid progression of neurological symptoms in an adult].

[On the wrong track: Misled by the patient history].

[An unusual cause for unilateral eye pain with double vision].

[Drug-induced liver injury (DILI)].

[What do Swiss doctors think about cardiovascular risk factors and guidelines?]

Polycation chain length determines the in vivo mRNA delivery efficiency of block copolymer micelles.

Driving Drugs Deeper: Force-Driven Microneedle Systems for Active Therapy and Their Road Towards Clinical Implementation.

Mumio Potentiates Temozolomide by Inducing Apoptosis and Ferroptosis in Glioblastoma Cells.

Current Targeted Nanoparticle Therapy for Alzheimer's Disease: Current Advances and Future Prospects.

Clinical Presentation, Diagnosis, Treatment, and Outcome of Heart Disease in Becker Muscular Dystrophy.

Clinical Pharmacology of Eplontersen, the First Approved GalNAc-Conjugated Antisense Oligonucleotide.

Related Experiment Videos

[Therapy of acute lung failure--is there really something new?]

Related Concept Videos

Related Articles